Skip to content
Open access · OA via Europe PMC

Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.

Alum EU, Izah SC, Uti DE, Ugwu OP, Betiang PA, Basajja M, Ejemot-Nwadiaro RI.

Drug design, development and therapy · 2025 · ▲ 4 citations

Abstract

<h4>Background</h4>Cellular senescence(definition) is a fundamental characteristic of aging, marked by permanent cell cycle cessation and the release of pro-inflammatory mediators. Although senescence plays advantageous roles in tissue regeneration and tumor suppression, its accumulation leads to aging-related illnesses and functional deterioration.<h4>Objective</h4>This review examines the processes of cellular senescence, its effects on aging and age-related disorders, and emerging therapeutic strategies to modulate senescence for promoting healthy aging.<h4>Methods</h4>A thorough literature review was performed using peer-reviewed studies on cellular senescence, its molecular pathways, and therapeutic interventions. Emphasis was placed on senolytics(definition), senomorphics, and lifestyle interventions that modulate senescence-associated pathways. Studies published in Scopus, Web of Science and PubMed between 2014-2025 were selected.<h4>Results</h4>Recent discoveries underscore the dual function of cellular senescence in aging and pathology. The senescence-associated secretory phenotype (SASP) fosters chronic inflammation and tissue dysfunction, connecting senescence to age-related diseases including cardiovascular conditions, dementia, and metabolic disorders. Therapeutic strategies, including senolytics (drugs that specifically eradicate senescent cells) and senomorphics (compounds that suppress SASP without killing cells), show promise in preclinical and clinical studies. Notably, dosing interals (intermittent vs continuous) influence both therapeutic efficacy and adverse events such as thrombocytopenia. Additionally, the state and limitations of clinical validation of aging biomarkers (eg, p16^INK4a, β-galactosidase) remain major hurdles for translation. Lifestyle interventions such as calorie restriction and exercise have also been identified as natural modulators of senescence pathways.<h4>Conclusion</h4>Targeting cellular senescence offers a promising avenue for promoting healthy aging and mitigating age-linked diseases. Continued research into senescence-modulating interventions may lead to novel therapeutics designed to prolong healthspan(definition) and lifespan.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.2147/dddt.s543211
Canonical
link ↗
Fetched
2026-05-31 MST

Cite this

APA
EU, A., SC, I., DE, U., OP, U., PA, B., M, B., &amp; RI., E. (2025). Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics. <em>Drug design, development and therapy</em>. https://doi.org/10.2147/dddt.s543211
Vancouver
EU A, SC I, DE U, OP U, PA B, M B, et al. Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics. Drug design, development and therapy. 2025. doi:10.2147/dddt.s543211.
BibTeX
@article{alum2025Target, title = {Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.}, author = {Alum EU and Izah SC and Uti DE and Ugwu OP and Betiang PA and Basajja M and Ejemot-Nwadiaro RI.}, journal = {Drug design, development and therapy}, year = {2025}, doi = {10.2147/dddt.s543211}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings